Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial

Fig. 2

Proportions of remissions; percentage of patients who achieved remission for each time point across the treatment groups. The denominator stays constant, meaning for example in the infliximab (IFX) + methotrexate (MTX) group that the proportion of patients in remission is always divided by 38 (the total number of patients included in this group at baseline). PL placebo

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us